Scientists from the Jules Bordet Institute and the University of Liège develop a predictive biomarker for a rare form of leukemia
Press release (08/11/2025) Scientists from the Jules Bordet Institute and the University of Liège develop a predictive biomarker for a rare form of leukemia Brussels, 8th of November 2025 – Researchers from the Jules Bordet Institute - H.U.B. and the GIGA Institute (University of Liège) have developed a new prognostic biomarker capable of identifying, among individuals infected with the HTLV-1 virus (Human T-cell Leukemia Virus…
(read more)